Indication · Laboratory Medicine & Pathology
Genetic and newborn screening
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
116
Cleared or approved since 2000
PMA and De Novo
30
Higher-risk or first-of-kind devices
Breakthrough devices
1
Authorized through June 30, 2026
Recruiting device trials
7
20 device trials in all
Breakthrough-designated devices
- Quest Diagnostics AAVrh74 Antibody ELISA CDxQuest Diagnostics Nichols Institute · 2025
Devices
116 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Access AFP (on DxI 9000 Analyzer)
Beckman Coulter, Inc. · PMA · Kit, Test, Alpha-Fetoprotein For Neural Tube Defects · newest 2025 · 5 decisions
59 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Remote Pregnancy Monitoring to Improve AccessPivotal-lookingCompleted
University of PennsylvaniaAcademic, hospital or other
NCT05847790 · 400 participants · Start May 25, 2023 · Primary completion Sep 26, 2025
Device: Invu monitoring belt · For: Fetal Monitoring
Sites: Philadelphia, Pennsylvania
19 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Abnormal Hemoglobin Quantitation (GKA)14
- Kit, Test, Alpha-Fetoprotein For Neural Tube Defects (LOK)12
- Enzyme Immunoassay, Non-Radiolabeled, Total Thyroxine (KLI)8
- System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection (NUA)8
- Device, Iontophoresis, Specific Uses (KTB)7
- Radioimmunoassay, 17-Hydroxyprogesterone (JLX)6
- Genetic Variant Detection And Health Risk Assessment System (PTA)5
- Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening (JBF)4
- Enzymatic Methods, Galactose (JIA)4
- System, Test, Biotinidase (NAK)4
- System, Test, Amino Acids, Free Carnitines And Acylcarnitines Tandem Mass Spectrometry (NQL)4
- Cancer Predisposition Risk Assessment System (QAZ)4
- Ninhydrin And L-Leucyl-L-Alanine (Fluorimetric), Phenylalanine (JNB)3
- Fluorescent Proc. (Qual.), Galactose-1-Phosphate Uridyl Transferase (KQP)3
- Alpha-D-Galactosidase A (Gla) Newborn Screening Test System (PQW)3
- N-Benzoyl-L-Arginine Ethyl Ester (U.V.), Trypsin (JNO)2
- Analyzer, Chromosome, Automated (LNJ)2
- System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection (PFX)2
- Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System (PJI)2
- Qualitative Cytomegalovirus Nucleic Acid-Based Detection Device For Congenital Cytomegalovirus Infection (QDZ)2
- Spinal Muscular Atrophy Newborn Screening Test System (QUE)2
- Catheter, Sampling, Chorionic Villus (LLX)1
- Enzyme Immunoassay, Inhibin-A (NDR)1
- Dna-Probe Kit, Human Chromosome (OYU)1
- Inherited Nucleotide Repeat Disorder Dna Test (OYV)1
- System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mutations & Variants Panel Sequencing Detection (PFR)1
- System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Variant Gene Sequence Detection (PFS)1
- System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations (PHJ)1
- Newborn Screening Specimen Collection Paper (PJC)1
- Autosomal Recessive Carrier Screening Gene Mutation Detection System (PKB)1
Research
- Device studies on newborn screening across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.